<DOC>
	<DOCNO>NCT01432782</DOCNO>
	<brief_summary>This study evaluate effect botulinum toxin 100 U saline , inject endoscopically distal esophagus , symptom manometry pattern patient diffuse esophageal spasm .</brief_summary>
	<brief_title>Botulinum Toxin Injection Treat Diffuse Esophageal Spasm</brief_title>
	<detailed_description>Patients select basis clinical diagnosis diffuse esophageal spasm , base endoscopy manometry . This sham-controlled cross-over study injection botulinum toxin saline , randomize order , distal esophagus . All patient undergone esophageal manometry show diffuse esophageal spasm , 24h pH monitoring/manometry quantify acid reflux . All drug prescribe affect esophageal motility ( nitrate , calcium antagonist ) stop study . After randomisation , patient undergo standard esophageal manometry ass baseline esophageal motility . On day patient ask fill set symptom questionnaire include dysphagia questionnaire . At endoscopy , active treatment group receive 8 x 12.5 unit , 0.5 ml , botulinum toxin A inject four quadrant esophagus 2 5 cm low esophageal sphincter . In Sham group 8 * 0.5 ml physiologic serum inject . The randomisation perform endoscopy unit nurse otherwise involve protocol . After 1 month stationary manometry new esophageal pH/manometry monitoring perform , follow second endoscopy injection saline botulinum toxin cross-over mode . At time second endoscopy patient fill dysphagia questionnaire . One month later , dysphagia questionnaire repeat . Subsequently , follow-up occur outpatient clinic 6 12 month , follow-up dysphagia questionnaires additional manometries endoscopy , unless clinical status deteriorates .</detailed_description>
	<mesh_term>Spasm</mesh_term>
	<mesh_term>Esophageal Spasm , Diffuse</mesh_term>
	<mesh_term>Esophageal Motility Disorders</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Spastic motor disorder upper GI tract</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Weight loss</keyword>
	<keyword>Dysphagia</keyword>
	<keyword>Esophageal hypermotility</keyword>
	<keyword>Chest Pain</keyword>
</DOC>